-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Beam Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2024.
- Beam Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$90.4M, a 163% decline year-over-year.
- Beam Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$377M, a 184% decline year-over-year.
- Beam Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$377M, a 184% decline from 2023.
- Beam Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$133M, a 54.2% increase from 2022.
- Beam Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$289M, a 22% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)